Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Bullboard Posts
Comment by inthnoon Mar 30, 2002 1:29pm
254 Views
Post# 4944830

RE: Is syb a good investment now? Be careful...

RE: Is syb a good investment now? Be careful...Onc is the pure play,of that there is no debate.We are not on this bb to debate whether or not we should buy syb. As for whether or not litigation would stop the distribution of onc shares.I am sure that the lawyers have already gone over this scenario and really,how can it be more equitable at this point but to distribute the onc shares to the syb shareholders.No lawsuit is going to get them anymore than that and after legal expenses most likely a lot less. There are a lot of companies that can fail,especially in phase 3 trials,this does not necessarily have anything to do with management.We must remember that whenever you buy a stock you take a risk. (buyer beware)This can happen with almost any company,the economy takes a downturn for example.Just take a look at all of the tech stocks. As an onc shareholder,in reality,how much more can we really expect.There are a couple of scenarios that I would have liked to have seen,but everyone has to be in agreement and it doesn't always happen.As I stated before timing may be critical in regards to this deal and do we want to really know what may happen if it doesn't go through. Everyone of course must vote the way they feel is best for them.If you don't like the deal and think that you can get better, than vote against.It's that simple. Inthno
Bullboard Posts